Subsequent Events	6 Months Ended
Jun. 30, 2023
Subsequent Events [Abstract]
Subsequent Events	14. Subsequent Events On July 10, 2023, ISO and Armata entered into a Credit and Security Agreement, under which we extended a term loan to Armata (the “Credit and Security Agreement”) in an aggregate amount of $25.0 million. The term loan is subject to an interest rate of 14% per annum and is due to mature on January 10, 2025. The Credit and Security Agreement is secured by substantially all of the assets of Armata and its domestic and foreign material subsidiaries. On July 10, 2023, ISO and Armata also executed an amendment to the Armata Convertible Note, discussed in Note 6 “Equity and Long-term Investments and Fair Value Measurements”, extending the maturity date from January 10, 2024 to January 10, 2025. In addition, Armata entered an amendment to the second amended and restated voting agreement dated February 9, 2022 with the Company and ISO, pursuant to which the Company and ISO agreed not to vote or take any action by written consent with respect to any common shares held by the Company and ISO that represent, in the aggregate, more than 49.5% of the total number of shares of Armata’s common stock for voting on the matters related to election or removal of Armata’s board members, amend the bylaws of Armata to reduce the maximum number of directors, or set the number of directors who may serve on the board of Armata. The voting agreement will expire on the earlier of the fifth anniversary of the original agreement effective date, January 26, 2021, or the approval by the FDA of any of Armata’s product candidates for marketing and commercial distribution.

Subsequent Events

6 Months Ended

Jun. 30, 2023

14. Subsequent Events

On July 10, 2023, ISO and Armata entered into a Credit and Security Agreement, under which we extended a term loan to Armata (the “Credit and Security Agreement”) in an aggregate amount of $25.0 million. The term loan is subject to an interest rate of 14% per annum and is due to mature on January 10, 2025. The Credit and Security Agreement is secured by substantially all of the assets of Armata and its domestic and foreign material subsidiaries. On July 10, 2023, ISO and Armata also executed an amendment to the Armata Convertible Note, discussed in Note 6 “Equity and Long-term Investments and Fair Value Measurements”, extending the maturity date from January 10, 2024 to January 10, 2025. In addition, Armata entered an amendment to the second amended and restated voting agreement dated February 9, 2022 with the Company and ISO, pursuant to which the Company and ISO agreed not to vote or take any action by written consent with respect to any common shares held by the Company and ISO that represent, in the aggregate, more than 49.5% of the total number of shares of Armata’s common stock for voting on the matters related to election or removal of Armata’s board members, amend the bylaws of Armata to reduce the maximum number of directors, or set the number of directors who may serve on the board of Armata. The voting agreement will expire on the earlier of the fifth anniversary of the original agreement effective date, January 26, 2021, or the approval by the FDA of any of Armata’s product candidates for marketing and commercial distribution.